Key result
Direct fetal therapy with intramuscular digoxin and intraperitoneal flecainide resulted in a favourable outcome in a fetus with refractory SVT and hydrops.
Why the study?
The role of direct fetal therapy requires highlighting in cases of refractory supraventricular tachyarrhythmia presenting with non-immune hydrops.
Does direct fetal therapy improve outcomes in refractory fetal SVT with hydrops?
Case Report (n=1)
Does direct fetal therapy improve outcomes in refractory fetal SVT with hydrops?
Direct fetal therapy with intramuscular digoxin and intraperitoneal flecainide may be an effective strategy for refractory fetal SVT with hydrops when transplacental therapy fails.
Answers are grounded in this paper and cite their sources.
May support direct fetal therapy in refractory fetal SVT with hydrops; leaves open need for prospective trials.
Supraventricular tachyarrhythmia (SVT) is the most common form of fetal tachyarrhythmias. The presentation can vary from ill-defined, non-sustained episodes of tachyarrhythmia to frank non-immune hydrops. The standard of care is transplacental therapy by treating the mother with oral antiarrhythmic drugs, followed by direct fetal therapy in refractory cases. We report a case of primigravida in her late 20s, who presented at 28.1 weeks of gestation with fetal hydrops and SVT. She was initially managed with oral digoxin and flecainide, but due to worsening hydrops, risk of fetal demise and extreme prematurity, further management by direct fetal therapy was given in terms of intramuscular digoxin and intraperitoneal flecainide. Following which, the fetus had a favourable outcome. This case highlights the possible role of direct fetal therapy in refractory cases of SVT.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2023) conducted a case report in Fetal hydrops and supraventricular tachyarrhythmia (SVT) (n=1). Direct fetal therapy (intramuscular digoxin and intraperitoneal flecainide) was evaluated on Fetal outcome. Direct fetal therapy with intramuscular digoxin and intraperitoneal flecainide resulted in a favourable outcome in a fetus with refractory SVT and hydrops.
Synapse has enriched 10 related papers. Consider them for comparative context: